Age-related normalization of the browning rate of collagen in diabetic subjects without retinopathy

The Journal of Clinical Investigation
V M MonnierT Yamashita

Abstract

The age-related changes in collagen-linked fluorescence (browning) were investigated in skin from subjects with long-standing type I diabetes. Overall browning rates were 2.4 times higher in diabetics than in controls (P less than 0.02) and slope intercept accurately reflected the mean age of onset of diabetes (11.6 vs. 11.2 yr), suggesting that the browning process has the attributes of a biological clock. Browning rates were not different in controls and diabetics without retinopathy (P greater than 0.05) but were 2.4 (P less than 0.05) and 2.7 (P less than 0.01) times increased in the presence of background and proliferative retinopathy, respectively. Compared with subjects with retinopathy, individual browning rates since onset of diabetes decreased with advancing age in subjects free of retinopathy (P less than 0.001). Extrapolation revealed that they would become identical to that of nondiabetic subjects by the age of 66.4 yr. These results suggest the presence of a mechanism that controls the browning rate of collagen in diabetics who do not develop retinopathy.

References

Jul 18, 1979·Biochimica Et Biophysica Acta·A M MadiaH M Kagan
Oct 1, 1975·Diabetes·C R HamlinJ H Luschin
Mar 24, 1975·Clinica Chimica Acta; International Journal of Clinical Chemistry·S K WadmanJ F Vliegenthart
Sep 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·H VlassaraA Cerami
Feb 13, 1986·The New England Journal of Medicine·V M MonnierR R Kohn
Feb 15, 1985·Biochemical and Biophysical Research Communications·M D TilsonM L Tanzer
Jan 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·V M MonnierA Cerami

❮ Previous
Next ❯

Citations

Jun 1, 1991·Diabetes/metabolism Reviews·R BrikP Vardi
Nov 13, 1989·Journal of Immunological Methods·J M BasgenA F Michael
Jul 1, 1990·Mechanisms of Ageing and Development·Z DeylK Macek
Mar 17, 1988·Biochimica Et Biophysica Acta·J ChaoL Chao
Jul 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·M H Dominiczak
Jan 1, 1995·The British Journal of Ophthalmology·K J HardyJ H Scarpello
Jul 1, 1993·The Journal of Clinical Investigation·P J BeisswengerT J Curphey
Sep 2, 1998·Annals of Periodontology·F NishimuraY Murayama
Mar 1, 1990·European Journal of Pediatrics·A L Rosenbloom
Oct 1, 1988·The Journal of Diabetic Complications·M P Cohen
Apr 1, 1989·The Journal of Diabetic Complications·A L Rosenbloom
Jun 17, 1998·The Journal of Pediatrics·J H SilversteinA L Rosenbloom
Feb 11, 2010·Journal of Diabetes Science and Technology·Marwood N EdigerJohn D Maynard
Mar 8, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Matthew A RobertsFrancesco L Ierino
Apr 5, 1990·The New England Journal of Medicine·T J Merimee
Aug 1, 1997·Archives of Biochemistry and Biophysics·I N ShipanovaR H Nagaraj
Jul 2, 2003·Experimental and Molecular Pathology·Alan W Stitt
Jun 1, 1992·Metabolism: Clinical and Experimental·P R OdettiR Rolandi
Dec 1, 1988·Analytical Biochemistry·A J Furth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.